Treatment of metastatic malignant melanoma during pregnancy with a BRAF kinase inhibitor: A case report

BACKGROUND: Melanoma accounts for 8% of all malignancies encountered during pregnancy. BRAF kinase inhibitors have shown promise in the treatment of late-stage melanoma; however, there have been no studies and only one previous case report regarding its use in pregnancy. CASE: A 25-year-old woman, g...

Descripción completa

Detalles Bibliográficos
Autores principales: Pagan, Megan, Jinks, Heather, Sewell, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829103/
https://www.ncbi.nlm.nih.gov/pubmed/31700806
http://dx.doi.org/10.1016/j.crwh.2019.e00142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829103/
https://www.ncbi.nlm.nih.gov/pubmed/31700806
http://dx.doi.org/10.1016/j.crwh.2019.e00142

Ejemplares similares